# Evaluation of the Efficacy of 0.08% Tacrolimus Nanoencapsulated Aqueous Solution Spray Vs. 0.1% Free Tacrolimus Commercial Ointment in the Treatment of Oral Lichen Planus

> **NCT06591884** · PHASE1,PHASE2 · RECRUITING · sponsor: **Hospital de Clinicas de Porto Alegre** · enrollment: 46 (estimated)

## Conditions studied

- Oral Erosive Lichen Planus

## Interventions

- **DRUG:** Tacrolimus modified-release
- **DRUG:** tacrolimus ointment 0.1%

## Key facts

- **NCT ID:** NCT06591884
- **Lead sponsor:** Hospital de Clinicas de Porto Alegre
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-03
- **Primary completion:** 2027-12
- **Final completion:** 2028-12
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2024-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06591884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06591884, "Evaluation of the Efficacy of 0.08% Tacrolimus Nanoencapsulated Aqueous Solution Spray Vs. 0.1% Free Tacrolimus Commercial Ointment in the Treatment of Oral Lichen Planus". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06591884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*